Reasons Lilly Remains a Buy: 3 Strong Drivers for Investors
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
Identify which tilts (such as value or quality) tend to be more tax-efficient in retirement index funds and how these choices affect after-tax performance and risk.
24,606 articlesInvestors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
Airbnb's Brian Chesky is reportedly exploring a dedicated AI lab, signaling his first major push into AI. The effort ...
A major payer shift could unlock stronger demand for Eli Lilly’s obesity and GLP-1 products. This in-depth analysis e...
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Investors who bought the Global X Lithium & Battery Tech ETF last June are seeing a 125% return as lithium demand imp...
An 11% one-day slide in the SPDR S&P Semiconductor ETF underscores how equal-weight funds magnify single-name moves, ...
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Oracle enters a critical earnings season with eyes on its AI pivot and data-center expansion. The market has piled on...
Chainlink's network shows a still-growing base of holders even as LINK trades off recent highs. With over 535,000 lin...
A researcher from Apex Crypto argues XRP’s flat price path reflects more than market dynamics, pointing to Citibank d...
SpaceX's planned IPO has drawn record demand, but market watchers warn buyers to scrutinize the order book for true d...